We are live on ! Find out more
PCM

Puissance Capital Management Portfolio holdings

AUM $17.3M
1-Year Est. Return 149.36%
This Fund
S&P 500
This Quarter Est. Return
-21.61%
1 Year Est. Return
+149.36%
3 Year Est. Return
+115.5%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$116M
AUM Growth
-$28.8M
Cap. Flow
+$4.57M
Cap. Flow %
3.94%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
+$9.17M

Top Sells

Rank Stock Value
1
KDMN
Kadmon Holdings, Inc.
KDMN
+$4.6M

Sector Composition

Rank Sector Weight
1 Technology 27.97%
2 Healthcare 19.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRAY
1
DELISTED
ViewRay, Inc.
VRAY
$44M 37.93%
6,842,975
– –
CHRN
2
ChronoScale Holdings
CHRN
$2.69B
$32.4M 27.97%
91,266
– –
BLPH
3
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$17.3M 14.88%
553,250
– –
KDMN
4
DELISTED
Kadmon Holdings, Inc.
KDMN
$14.6M 12.55%
3,425,000
-1,075,000
-24% -$4.6M
TCON
5
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$7.74M 6.67%
+16,814
New +$9.17M

Similar funds

FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
IAM
ICM Asset Management Spokane, Washington $18.1M AUM 30.29% 1-Year Est. Return
FP
FFL Partners San Francisco, California $16.1M AUM 46.91% 1-Year Est. Return
AF
AMG Funds Stamford, Connecticut $20M AUM 3.75% 1-Year Est. Return
TCS
Texas Children's Houston, Texas $20.5M AUM 51.2% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
PCM
Proxima Capital Management New York $21M AUM 3.49% 1-Year Est. Return
NC
Numen Capital London, United Kingdom $13.5M AUM 47.6% 1-Year Est. Return

Puissance Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Puissance Capital Management held 5 positions worth $116M, down 20% from $145M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Puissance Capital Management deployed $4.57M of net new capital in Q1 2018, opening 1 new position. Its largest new stake was TRACON Pharmaceuticals, Inc. Common Stock: 16,814 shares worth $7.74M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare.

On the sell side, the largest reduction was Kadmon Holdings, Inc., an estimated $4.6M trimmed.

  • Puissance Capital Management's largest Q1 2018 buy was TRACON Pharmaceuticals, Inc. Common Stock: 16,814 shares worth $7.74M.
  • Puissance Capital Management's biggest Q1 2018 reduction was Kadmon Holdings, Inc., cutting an estimated $4.6M.
  • Puissance Capital Management's ten largest holdings make up 100% of its $116M portfolio in Q1 2018.
  • Puissance Capital Management opened 1 new position and closed 0 in Q1 2018.
  • Puissance Capital Management's portfolio value fell 20% quarter-over-quarter to $116M.

Based on Puissance Capital Management's 13F filing for Q1 2018, filed 15 May 2018.